Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Hait

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|November 22, 1990
Ondansetron and cisplatin-induced nausea and vomitingW N Hait
New Jersey Medicine : the Journal of the Medical Society of New Jersey|July 15, 2005
People of the year. William N. Hait, MD, PhD. Interview by Bill BerlinW N Hait
Anti-Cancer Drug Design|October 1, 1987
Targeting calmodulin for the development of novel cancer chemotherapeutic agentsW N Hait
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
The prognostic and predictive values of ECD-HER-2W N Hait
Annual Review of Pharmacology and Toxicology|January 1, 1977
Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agentsB Weiss, W N Hait
Nature|January 29, 1976
Increased cyclic nucleotide phosphodiesterase activity in leukaemic lymphocytesW N Hait, B Weiss
Biochimica Et Biophysica Acta|March 29, 1977
Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytesW N Hait, B Weiss
Molecular Pharmacology|November 1, 1979
Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular formsW N Hait, B Weiss
Clinical Research|October 1, 1988
Report of the AFCR Public Policy Committee: current issues in public policyB Firth, W N Hait
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cellsD M Bagaglio, W N Hait
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|November 22, 1990
Ondansetron and cisplatin-induced nausea and vomitingW N Hait
New Jersey Medicine : the Journal of the Medical Society of New Jersey|July 15, 2005
People of the year. William N. Hait, MD, PhD. Interview by Bill BerlinW N Hait
Anti-Cancer Drug Design|October 1, 1987
Targeting calmodulin for the development of novel cancer chemotherapeutic agentsW N Hait
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
The prognostic and predictive values of ECD-HER-2W N Hait
Annual Review of Pharmacology and Toxicology|January 1, 1977
Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agentsB Weiss, W N Hait
Nature|January 29, 1976
Increased cyclic nucleotide phosphodiesterase activity in leukaemic lymphocytesW N Hait, B Weiss
Biochimica Et Biophysica Acta|March 29, 1977
Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytesW N Hait, B Weiss
Molecular Pharmacology|November 1, 1979
Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular formsW N Hait, B Weiss
Clinical Research|October 1, 1988
Report of the AFCR Public Policy Committee: current issues in public policyB Firth, W N Hait
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cellsD M Bagaglio, W N Hait
Pageof 9